Skip to main content
NewslettersWatchlist

Latest

opinion
Canadians deserve a transparent report into the COVID-19 pandemic
Lynora Saxinger and Braden Manns
canada
More graduates will pursue family medicine in Canada, up from 2023
The Family Clinic in Marathon, Ontario, on Friday, November 11, 2022. David Jackson / The Globe and Mail
canada
Medical schools raise alarm over declining interest in family medicine
FILE PHOTO: People walk on the grounds of the University of Toronto in Toronto, Ontario, Canada September 9, 2020. Picture taken September 9, 2020. REUTERS/Carlos Osorio/File Photo
canada
University of B.C. to add 778 technology seats with $23 million from province
The University of British Columbia will add 778 more student spaces for technology-related programs over the next six years through a $23-million investment from the provincial government. The UBC sign is pictured at the University of British Columbia in Vancouver, Tuesday, April 23, 2019. THE CANADIAN PRESS/Jonathan Hayward
canada
Doctors are working less than they did 30 years ago, with married men putting in fewer hours, study says
A trauma room in the emergency department of St. Michael's Hospital in Toronto on September 20, 2019. Photo by Deborah Baic / The Globe and Mail
world
Biden orders women’s health research expansion
Video2:07
report on business
Manulife drug plan members continue to face barriers when trying to fill prescriptions at pharmacies of their choice
Signage is seen on Manulife Financial Corp.'s office tower in Toronto, Tuesday, Feb. 11, 2020. THE CANADIAN PRESS/Cole Burston
u.s. business
U.S. FDA delays decision on whether to approve Eli Lilly’s Alzheimer’s drug, calls for advisory panel
FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo
world
$1-billion donation makes New York medical school tuition free and transforms students’ lives
The logo of the Albert Einstein College of Medicine is seen on a building in the campus, Tuesday, Feb. 27, 2024, in the Bronx borough of New York. The medical school will be tuition-free for all students from now on thanks to a $1 billion donation from former professor Ruth Gottesman, the widow of a Wall Street investor. (AP Photo/Mary Altaffer)
opinion
We’ve won the war on smoking – except that we haven’t
Jan Pezarro
report on business
Exclusive deals between insurance companies and pharmacies becoming more prevalent in Canada
Kari Wutzke, poses for a photograph at her daughter's home in Abbotsford, B.C, on Friday, February 16, 2024. Wutzke is a patient who has to navigate exclusive deals with pharmacies and drug suppliers for her tremfya prescription, to treat her arthritis. Tijana Martin/ The Globe and Mail
report on business
Manulife-Loblaw deal to deliver specialty drugs sparks access, competition concerns
Some pharmacare policy experts are raising concerns about competition and patient access to much-needed medication after Manulife Financial Corp. announced certain prescription drugs under its coverage are now only available at Loblaw Cos. Ltd. pharmacies. Signage is seen on Manulife Financial Corp.'s office in Toronto on Feb. 11, 2020. THE CANADIAN PRESS/Cole Burston
opinion
To reduce ER wait times, hospitals must stop using them as in-patient warehouses
James Worrall and Paul Pageau
world
Suspected fake Ozempic linked to three U.S. cases of hypoglycemia
FILE PHOTO: A pharmacist displays a box of Ozempic, a semaglutide injection type 2 drug used for treating diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo
opinion
To fix Canada’s crumbling health care system, we need better tools than duct tape
André Picard
explainer
Canada has an Ozempic shortage as demand surges. What to know about the drug being used for weight loss and its availability
FILE - The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. A preliminary review of side effects from popular drugs used to treat diabetes and obesity shows no link with suicidal thoughts or actions, the U.S. Food and Drug Administration said Thursday, Jan. 11, 2024. But the agency also said officials cannot definitively rule out that “a small risk may exist" and that they'll continue to look into reports regarding more than a dozen drugs, including Ozempic, Wegovy and Mounjaro. (AP Photo/David J. Phillip, File)
world
Shipment of medicine for hostages held by Hamas arrives in Gaza as Israel-Hamas deal moves ahead
Smoke rises from Gaza, amid the ongoing conflict between Israel and the Palestinian Islamist group Hamas, as seen from southern Israel, January 17, 2024. REUTERS/Tyrone Siu
alberta
Opposition calls for Alberta to dump imported fever medicine amid health concerns
Alberta Premier Danielle Smith speaks during a news conference in Edmonton on Wednesday, Nov. 8, 2023. The Opposition says it’s time to dump once and for all the remaining bottles of imported Turkish children’s fever medicine, given new reports stating the liquid clogs hospital feeding tubes and can put newborns at risk. THE CANADIAN PRESS/Jason Franson
report on business
Spirit Healthcare Group is bridging health gaps for Indigenous communities
world
U.S. FDA approves two gene therapies for sickle cell disease
FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
world
U.K. authorizes gene therapy for blood disorders in world first
FILE - This microscope photo provided on Oct. 25, 2023, by the Centers for Disease Control and Prevention shows crescent-shaped red blood cells from a sickle cell disease patient in 1972. Britain's medicines regulator has authorized the world's first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K. In a statement on Thursday, Nov. 16, 2023, the Medicines and Healthcare Regulatory Agency said it approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel prize in 2020. (Dr. F. Gilbert/CDC via AP, File )
report on business
FDA approves new version of diabetes drug Mounjaro for weight loss
FILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis on April 26, 2017. A new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight. (AP Photo/Darron Cummings, File)
canada
Ontario to lower age for mammograms to 40 from 50 next year
Medical personnel use a mammogram to examine a woman's breast for breast cancer. Breast cancer patients are unsettled: The drug tamoxifen, which accompanies tens of thousands for years, is experiencing massive supply shortages. Tamoxifen is used in aftercare - the aim is to prevent a relapse. (to dpa "Tamoxifen supply bottleneck unsettles breast cancer patients")
british columbia
Western Canada: Alberta on the hook for children’s medication that may never arrive
Alberta Premier Danielle Smith addresses the children’s medication shortage in Edmonton, on Tuesday, December 6, 2022. The province has secured five million bottles of children’s acetaminophen and ibuprofen for Alberta families. THE CANADIAN PRESS/Jason Franson
canada
Quebec tuition hike for out-of-province students already weighing on high schoolers
McGill University is seen Friday, October 13, 2023 in Montreal. Quebec's decision to raise university tuition for out-of-province students is already weighing on high schoolers and their families.THE CANADIAN PRESS/Ryan Remiorz
canada
Ozempic and similar drugs linked to gastrointestinal conditions, Canadian researchers find
People using diabetes drugs such as Ozempic for weight loss are at higher risk of pancreatitis, bowel obstruction and stomach paralysis compared with another medication approved specifically for obesity management, a University of British Columbia study suggests. Diabetes drug Ozempic is shown at a pharmacy in Toronto on Wednesday, April 19, 2023. THE CANADIAN PRESS/Joe O'Connal
opinion
End the fuzzy pricing of pet medicine
The Editorial Board
opinion
AI holds much promise in medicine, beginning with easing doctors’ paperwork
André Picard
canada
For fly-in doctors of Manitoba, work is far from home but close to the action
world
Popular nasal decongestant doesn’t actually relieve congestion, experts say
FILE - Sudafed and other common nasal decongestants containing pseudoephedrine are on display behind the counter at Hospital Discount Pharmacy in Edmond, Okla., Jan. 11, 2005. The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient. Advisers to the Food and Drug Administration voted unanimously on Tuesday, Sept. 12, 2023 against the effectiveness of the ingredient found in popular versions of Sudafed, Allegra, Dayquil and other medications sold on pharmacy shelves. (AP Photo, File)
hope or hype?
What does it cost to try to stay young forever? Inside the hyped-up world of anti-aging
Clockwise from left: Bryan Johnson has spent millions on therapies in an effort to reverse his biological clock; Peter Thiel says he will have his body cryogenically frozen when he dies; Jeff Bezos has invested in a startup that flushes out aged cells.
world
Biden administration takes abortion pill dispute to U.S. Supreme Court
FILE - Boxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., on March 16, 2022. The Supreme Court is being asked to reverse an appellate ruling that would cut off mail-order access to a drug used in the most common method of abortion in the United States. In an appeal filed Friday, Sept. 8, 2023, Danco Laboratories, the manufacturer of mifepristone, argued that federal judges should not second-guess the Food and Drug Administration's approval of the drug or the conditions under which it is dispensed. The Biden administration also was expected to file an appeal. (AP Photo/Allen G. Breed, File)
world
Blood test for Parkinson’s disease promising in early study
FILE - The Biogen Inc., headquarters is pictured on March 11, 2020, in Cambridge, Mass. Biogen is spending more than $7 billion to buy Reata Pharmaceuticals and bolster its rare disease treatments. The Alzheimer’s treatment developer said Friday, July 28, 2023, it will pay $172.50 in cash for each share of Reata in a deal it expects to close by the end of this year. (AP Photo/Steven Senne, File)
report on business
10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions
FILE - President Joe Biden speaks about health care and prescription drug costs at the University of Nevada, Las Vegas, Wednesday, March 15, 2023, in Las Vegas. Biden's administration will announce on Tuesday, Aug. 29, 2023, the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs. (AP Photo/Evan Vucci)
report on business
US FDA approves Regeneron’s drug for ultrarare blood disease
FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid/File Photo